Haemonetics 1st Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 1st Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) Tops Q1 EPS by 18c; Raises FY20 EPS Guidance Above Consensus

August 6, 2019 6:29 AM EDT

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.81, $0.18 better than the analyst estimate of $0.63. Revenue for the quarter came in at $238 million versus the consensus estimate of $237.72 million.

Link to Q1... More